- Home
- ACHV vs STRW Comparison
ACHV vs STRW Comparison
Compare ACHV & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- STRW
- Stock Information
- Founded
- ACHV N/A
- STRW 2015
- Country
- ACHV United States
- STRW United States
- Employees
- ACHV N/A
- STRW N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- STRW Real Estate Investment Trusts
- Sector
- ACHV Health Care
- STRW Real Estate
- Exchange
- ACHV Nasdaq
- STRW Nasdaq
- Market Cap
- ACHV 131.2M
- STRW 123.8M
- IPO Year
- ACHV N/A
- STRW N/A
- Fundamental
- Price
- ACHV $2.55
- STRW $11.06
- Analyst Decision
- ACHV Strong Buy
- STRW Strong Buy
- Analyst Count
- ACHV 3
- STRW 4
- Target Price
- ACHV $14.33
- STRW $12.72
- AVG Volume (30 Days)
- ACHV 652.7K
- STRW 25.6K
- Earning Date
- ACHV 08-07-2025
- STRW 08-08-2025
- Dividend Yield
- ACHV N/A
- STRW 5.06%
- EPS Growth
- ACHV N/A
- STRW 27.31
- EPS
- ACHV N/A
- STRW 0.59
- Revenue
- ACHV N/A
- STRW $135,145,000.00
- Revenue This Year
- ACHV N/A
- STRW $32.86
- Revenue Next Year
- ACHV N/A
- STRW $3.50
- P/E Ratio
- ACHV N/A
- STRW $18.68
- Revenue Growth
- ACHV N/A
- STRW 24.72
- 52 Week Low
- ACHV $1.84
- STRW $8.70
- 52 Week High
- ACHV $5.31
- STRW $12.90
- Technical
- Relative Strength Index (RSI)
- ACHV 46.32
- STRW 60.62
- Support Level
- ACHV $2.37
- STRW $10.62
- Resistance Level
- ACHV $2.56
- STRW $11.25
- Average True Range (ATR)
- ACHV 0.12
- STRW 0.43
- MACD
- ACHV 0.01
- STRW 0.09
- Stochastic Oscillator
- ACHV 47.37
- STRW 84.80
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.